Klanbicid 500 mg Powder for solution for infusion.
PDF Leaflet Revision Date: 03 June 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections due to susceptible organisms requiring parenteral therapy.
Dosage (summary)
1000 mg daily in two 500 mg doses via IV infusion over 60 minutes.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Safety during pregnancy and lactation not established; excreted in breast milk.
Key Drug Interactions
- Astemizole
- Cisapride
- Domperidone
- Pimozide
- Terfenadine
- Ergot alkaloids
- Oral midazolam
- Statins (lovastatin, simvastatin)
Contraindications
- Hypersensitivity to clarithromycin
- QT prolongation history
- Severe hepatic failure with renal impairment
Common side effects
- Abdominal pain
- Diarrhoea
- Nausea
- Vomiting
- Taste perversion
Counselling Points
- Monitor for signs of hepatic disease.
- Avoid use with contraindicated medications.
- Report any severe allergic reactions.
Serious warnings
- Risk of QT prolongation and cardiac dysrhythmias
- Pseudomembranous colitis
- Severe hepatic dysfunction
Important Disclaimer
The Klanbicid 500 mg Powder for solution for infusion. professional information leaflet below is the property of Juno Pharma Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
